Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

NCT00984464 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Melanoma

Interventions

BIOLOGICAL: REOLYSIN
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Oncolytics Biotech

Collaborators

[object Object]